HitGen Inc. (SHSE: 688222)
Health Care · Life Sciences Tools & Services · CN
CN¥44.69
+2.31% today · +82.6% 1Y
HitGen Inc. (SHSE: 688222) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.67B.
Over the last twelve months the share price has gained 82.6%, trading between 21.46 and 47.58.
Tweenvest scores HitGen Inc. across four factors: quality 72/100, value 24/100, growth 92/100, dividend 9/100. Its strongest factor is growth.
688222 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.67B
- Revenue (TTM)
- $94.89M
- P/E
- 127.16
- EPS
- 0.35
- Dividend yield
- 0.29%
- Beta (5Y)
- 0.58
- 52-week high
- CN¥47.58
- 52-week low
- CN¥21.46
- Avg volume (3M)
- —
- Shares outstanding
- 400.68M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tecan Group AGSWX: TECN | $3.44B | CHF239.20 | +3.46% |
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.40B | Rs1,541.20 | -3.20% |
| Shanghai Haoyuan Chemexpress Co., Ltd.SHSE: 688131 | $3.16B | CN¥99.47 | -3.93% |
| Oxford Nanopore Technologies plcLSE: ONT | $2.84B | £2.12 | -3.72% |
| GemPharmatech Co., Ltd.SHSE: 688046 | $2.31B | CN¥37.94 | +5.62% |
| LigaChem Biosciences Inc.KOSDAQ: A141080 | $2.25B | ₩82,300.00 | +1.86% |
| Peptron, Inc.KOSDAQ: A087010 | $2.24B | ₩129,500.00 | -11.00% |
| Shanghai InnoStar Bio-tech Co., Ltd.SHSE: 688710 | $2.21B | CN¥105.20 | +9.58% |
Figures last refreshed Oct 4, 2026.